Creative Biolabs-Immuno-oncology

Anti-CD22 (clone 2B322Q) SynExpress E1-Cy2-IR-E CD8+ T Cells (CAT#: ITS-1124-CR54)

DatasheetDatasheet
Description
This product utilizes CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone 2B322Q). We employs the Lentivirus (EF1α-Cy2-IRF-EcoRI) vector components and the SynExpress system of the histone modification sites Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
CD22
Clone
2B322Q
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy2
Promoter
EF1α
Effector Gene
IRF
Insertion Sites
EcoRI
Gene Modification
Knock-in
Modification Domain
Histone modification sites
Carrier Type
Lentivirus
Transformation Accuracy
0.91
Cell Culture
Microcarrier Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.